Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16674697 | 0.87 | PLA2G7 (0.44) | PLA2G7CHRM2MEN1CYP1A2CYP2C19 | |
| SCHEMBL16674711 | 0.82 | POLB (0.42) | PLA2G7KMT2A | |
| Hydrochloric Acid SCHEMBL20556405 | 0.81 | ALDH1A1 (0.41) | PLA2G7KMT2A | |
| SCHEMBL16674694 | 0.81 | PLA2G7 (0.40) | PLA2G7CHRM2MEN1CYP1A2CYP2C19 | |
| SCHEMBL16674706 | 0.78 | CHRM2 (0.31) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL16674699 | 0.77 | MEN1 (0.47) | PLA2G7MEN1KMT2A | |
| SCHEMBL16674695 | 0.70 | PLA2G7 (0.46) | PLA2G7MEN1KMT2A | |
| SCHEMBL7968322 | 0.68 | PLA2G7 (0.47) | PLA2G7 | |
| SCHEMBL16674710 | 0.68 | ALDH1A1 (0.37) | KMT2A | |
| SCHEMBL11272468 | 0.67 | MGLL (0.47) | PLA2G7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150118179-A1 | BIOCIDAL COMPOUNDS AND METHODS FOR USING SAME | UNIVERSITY OF MANITOBA (CA) | 2015-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150118179-A1 | BIOCIDAL COMPOUNDS AND METHODS FOR USING SAME | NQO2, DLAT, TYR | PLA2G7 3664/4885CHRM2 597/4885MEN1 3108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.